Pantoprazole Sodium 40 mg DR Tablets Under Fasting Conditions
Status:
Completed
Trial end date:
2003-12-01
Target enrollment:
Participant gender:
Summary
The objective of this study is to compare the relative bioavailability of pantoprazole sodium
40 mg delayed-release tablets ( manufactured by TEVA Pharmaceuticals Industries, Ltd. and
distributed by TEVA Pharmaceuticals USA) with that of PROTONIX® 40 mg delayed-released
tablets (Wyeth-Ayerst) in Healthy, adult, non-smoking subjects under fasting conditions.